Clinical significance of PD-L1-positive cancer-associated fibroblasts in pN0M0 non-small cell lung cancerKoji Teramoto, Yataro Daigo, Mitsuaki Ishida et al.|Lung Cancer|2019Cited by 59
Hypoxia‑induced galectin‑3 enhances RhoA function to activate the motility of tumor cells in non‑small cell lung cancerYoko Kataoka, Jun Hanaoka|Oncology Reports|2018Cited by 27
Biphasic prognostic significance of PD-L1 expression status in patients with early- and locally advanced-stage non-small cell lung cancerKoji Teramoto, Yataro Daigo, Tomoyuki Igarashi et al.|Cancer Immunology Immunotherapy|2020Cited by 12
Prognostic impact of soluble PD-L1 derived from tumor-associated macrophages in non-small-cell lung cancerKoji Teramoto, Yataro Daigo, Tomoyuki Igarashi et al.|Cancer Immunology Immunotherapy|2023Cited by 11
Abstract 5080: HIF-1 is responsible for the induction of cancer-associated fibroblasts in hypoxic tumor microenvironmentKoji Teramoto, Yataro Daigo, Jun Hanaoka et al.|Cancer Research|2015Cited by 1